Study examines public understanding of drug rationing amid AIDS epidemic

March 30, 2017 by Carla Reiter, University of Chicago
Moureen, a young mother of two children, is part of generation in Malawi that has grown up amid an HIV-AIDS epidemic in the east African nation. Credit: Gregory Collins

In Balaka, Malawi, HIV-AIDS has been an epidemic for so long that young adults have never known any other reality. Anti-retroviral drugs, which keep infected people healthy, are available, but there aren't enough to treat everyone who needs them. So policymakers in the east African nation must prioritize.

Rationing is complicated, and priorities have shifted many times over the years. Young adults in Balaka are often unaware about what the current distribution strategies actually are, despite the fact that their lives, and the lives of their family members, hang in the balance. People often end up confused and suspicious of a system of rationing that has not been clearly communicated, while having clear ideas about who should get the drugs first.

Researchers in a new study find the ideas among community members are surprisingly quite similar to what actually happens. The research was published recently in the Journal of the International AIDS Society.

Co-authors Jenny Trinitapoli, associate professor of sociology at University of Chicago, and Sara Yeatman, associate professor of health and behavioral sciences at the University of Colorado, Denver, examined what think about how are distributed. Their findings suggest that decision makers who allocate anti-HIV drugs should make their policies—and the rationale behind them—clear to the publics they serve, in part because such steps would help ensure people continue to come to health clinics.

"The priority of policymakers has not always been on communicating their priorities to the average people." Trinitapoli said. "But questions of access to anti-retroviral drugs and fairness in allocating them have consequences for how people will engage with the health care system broadly. We are trying to see opportunities for improving relationships between people who are affected by policy and the people who are carrying it out."

The new findings are part of a long-term project begun by Trinitapoli and Yeatman in 2009. They have been following a group of 1,500 women and 600 men through a period of their lives in which most people form relationships and have children—also the time of life when most new HIV infections occur. Respondents have been interviewed at four-month intervals to try to shed light on how young people deal with reproduction in an AIDS epidemic.

"In a generalized epidemic where as many as 20 percent of people in communities are infected, HIV is really part of the context," Trinitapoli said. "The question of whether someone is infected or not has become secondary to the fact that everyone is trying to make decisions, forge relationships and start their families with a backdrop of a deadly condition swirling around them. It makes for very complex interactions for young adults, especially as they navigate relationships and decisions about childbearing."

In the most recent study, Yeatman and Trinitapoli wanted to find out what people understood about a new government policy that shifted priority access to drugs from the sickest people to pregnant women who are HIV positive, regardless of their health.

Most Balakans are semi-literate, so the researchers used pictures to probe what people think happens in the clinics under the new allocation system. Participants were given six drawings—a healthy-looking pregnant woman and a sick-looking one; a healthy woman who was not pregnant and a sick one; a healthy man and a sick one. They were asked to arrange them according to who they thought was likely to get anti-retroviral drugs and who wasn't. Then the researchers asked the study participants to re-arrange the drawings according to what they thought would be the fairest way to distribute the drugs.

Only about a third of women and 20 percent of their male partners showed that they understood how the drugs were being distributed. But when those who didn't understand moved the cards to show what they thought would be more fair, they illustrated the policy that is actually in place.

"A lot of people moved the healthy-looking pregnant woman up, to show that she should be prioritized," Trinitapoli said. "So the sensibilities around fairness are highly consistent with the policy. But the policy hasn't been communicated to a general audience. And that gap between what people think is happening and what people think is fair is pretty unnecessary."

In the next phase of their research, Trinitapoli and Yeatman plan to look at how HIV-AIDS reduces trust between partners and de-stabilizes relationships, creating an environment in which the disease can spread more quickly. And they want to look at how understandings of the disease are changing as more people gain access to treatment and live long, normal lives.

"In a place like Malawi, where the GDP is one of the lowest in the world and most people live as subsistence farmers, can it really happen that HIV will become a chronic, manageable condition like it is in the United States?" Trinitapoli asked.

Explore further: HIV uncertainty pushes Malawians to want children earlier

More information: Sara Yeatman et al. Awareness and perceived fairness of option B+ in Malawi: a population-level perspective, Journal of the International AIDS Society (2017). DOI: 10.7448/IAS.20.1.21467

Related Stories

HIV uncertainty pushes Malawians to want children earlier

December 1, 2011
People in Malawi who are uncertain about their HIV status are more eager to start families than those who are certain of their HIV status, according to researchers.

Religions play positive role in African AIDS crisis

September 11, 2012
While the Western press often targets religious groups for their roles in handling the African AIDS crisis, these groups tend to play positive—and critical—roles in fighting the epidemic, according to sociologists.

WHO: On track to 15 million on AIDS drugs by 2015

July 26, 2012
(AP) — The World Health Organization says the global target of 15 million people taking life-saving AIDS drugs by 2015 is just a first step.

A quarter of SAfrica's HIV carriers are young women

December 1, 2014
About one quarter of South Africans newly infected by HIV are girls and women between the ages of 15 and 24, Deputy President Cyril Ramaphosa said Monday.

After decades of research, why is AIDS still rampant?

December 2, 2016
Today is World AIDS Day. More than three decades after the virus was first discovered, 5,753 people will become HIV infected today.

Recommended for you

New method allows scientists to study how HIV persists

April 24, 2018
After 35 years of rigorous research, there is still no cure for HIV. Current drugs can be used to halt the infection, but fall short of reaching hidden reserves of dormant virus that can lurk for life within infected white ...

HIV-1 viruses transmitted at birth are resistant to antibodies in mother's blood

April 19, 2018
Of the genetically diverse population of HIV-1 viruses present in an infected pregnant woman, the few she might transmit to her child during delivery are resistant to attack by antibodies in her blood, according to new research ...

Top HIV cure research team refutes major recent results on how to identify HIV persistence

April 18, 2018
An international team focused on HIV cure research spearheaded by The Wistar Institute in collaboration with the University of Pennsylvania and Vall d'Hebron Research Institute (VHIR) in Barcelona, Spain, established that ...

Scientists discover new way that HIV evades the immune system

April 17, 2018
Scientists have just discovered a new mechanism by which HIV evades the immune system, and which shows precisely how the virus avoids elimination. The new research shows that HIV targets and disables a pathway involving a ...

Team develops new way to fight HIV transmission

April 16, 2018
Scientists at the University of Waterloo have developed a new tool to protect women from HIV infection.

Genetically altered broadly neutralizing antibodies protect monkeys from HIV-like virus

April 16, 2018
Two genetically modified broadly neutralizing antibodies (bNAbs) protected rhesus macaques from an HIV-like virus, report scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.